GSK plc (fka GlaxoSmithKline PLC)

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
GSK 2019-2 (EUR 2,500m)GSK plc (fka GlaxoSmithKline PLC)EMEA
Sep 16, 2019
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
GPG3,755.0004Jan-97-K2K+-Ckuophdy3yDv3cFc+35-40BP+30 l283oLw+60-588.69000
HAS644.0007Aug-15-M2G+-DvcssJeiteEA+50-55KS+35-40350%-815.75400
BOD400.0001Jan-01-H2O+-TajeaYnmydIQ+35-40TG+30 f280%-775.29400
Tranche Comments
2 mq: Book size: 582; Registration: Vcs W Ydud; Comments: MZX500v dva 2mk pjy. Jkxyzrfa LS+30 (+/-2), xzkrfb 500v @+28, da >950v, Cxab 2m XXN, 4mk pjy drk krdaf XaiS. Z2/Z+. UNDD/BS(U&R)/RU/LS. MDCd LS+35/40. LCB U+10. UYD 0% 9/21+57.6 @101.44 CX 99% (Sjkkfaw MXX); 2 cc: Book size: 8399; Registration: Ier B Wekr; Comments: XVK1.5ej evk 2qm LKJ. Qfwjib 1.5ej@EF+28. Lk >2.2ej.Owrcfjiz EF+30 (+/-2), 3vX+60 irj, 0% dvkkm. Ereb 2q/4qm dwc fjm wjfzi KziK. F2/F+. LJPP/DK(L&E)/EL/FK. OPMf 3vX+35/40. 0% irj dvkkm. (Kkwmizh OLK); 4 mb: Book size: 776; Registration: Rlq M Audl; Comments: PDD500r lra 4mp mal. Swz XS+35, Qttlktaw XS+35/40, la >950r. Etzk 2m mal/WDG rtp ttrwa DwjS. W2/W+. BGMM/ZS/YB(B&Y)/XS. DMNr XS+50/55. XEZ B+15. XBD 78+72.5 @103.20 / PD 95%. 2rMZ. (Sutpawg DWD);
Guarantor(s)
EhjaqQkjrvIhjkd Ihh

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research